Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis
Related Posts
He C, Yanagisawa H, Hsiai TK, Xu S. Mouse models of aortic aneurysm and dissection: pathophysiological insights and translational perspectives. J Adv Res. 2026 Aug[...]
Lu F, Ahmed AA, Zhang S, Raman VK, Patel SS, Vargas JD, Fonarow GC, Heidenreich PA, Cleland JGF, Anker SD, Böhm M, Metra M, Zile[...]
Andrade-Bucknor S, Barforoshi S, Le DE, Lyubarova R, Chung J. Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis[...]